WO1999045784A1 - Bactericides - Google Patents
Bactericides Download PDFInfo
- Publication number
- WO1999045784A1 WO1999045784A1 PCT/JP1999/001183 JP9901183W WO9945784A1 WO 1999045784 A1 WO1999045784 A1 WO 1999045784A1 JP 9901183 W JP9901183 W JP 9901183W WO 9945784 A1 WO9945784 A1 WO 9945784A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fungicide
- extract
- chitosan
- eucalyptus
- leaves
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title abstract description 99
- 239000003899 bactericide agent Substances 0.000 title abstract description 30
- 229920001661 Chitosan Polymers 0.000 claims abstract description 88
- 239000000284 extract Substances 0.000 claims abstract description 86
- 244000166124 Eucalyptus globulus Species 0.000 claims abstract description 26
- 239000002798 polar solvent Substances 0.000 claims abstract description 10
- 150000002334 glycols Chemical class 0.000 claims abstract description 6
- 150000001298 alcohols Chemical class 0.000 claims abstract description 5
- 239000000417 fungicide Substances 0.000 claims description 92
- 230000000855 fungicidal effect Effects 0.000 claims description 84
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 71
- 241000894006 Bacteria Species 0.000 claims description 44
- -1 glycerin fatty acid ester Chemical class 0.000 claims description 38
- 235000013372 meat Nutrition 0.000 claims description 34
- 241000196324 Embryophyta Species 0.000 claims description 28
- 239000000645 desinfectant Substances 0.000 claims description 28
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 26
- 239000000194 fatty acid Substances 0.000 claims description 26
- 229930195729 fatty acid Natural products 0.000 claims description 26
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 23
- 235000011187 glycerol Nutrition 0.000 claims description 21
- 239000003495 polar organic solvent Substances 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 16
- 238000012545 processing Methods 0.000 claims description 15
- 239000002904 solvent Substances 0.000 claims description 15
- 241001465754 Metazoa Species 0.000 claims description 14
- 239000000341 volatile oil Substances 0.000 claims description 13
- 210000003278 egg shell Anatomy 0.000 claims description 11
- 235000013305 food Nutrition 0.000 claims description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 5
- 206010000496 acne Diseases 0.000 claims description 5
- 241000223238 Trichophyton Species 0.000 claims description 4
- 230000002147 killing effect Effects 0.000 claims description 4
- 238000001256 steam distillation Methods 0.000 claims description 4
- 150000002576 ketones Chemical class 0.000 claims description 3
- 241000271566 Aves Species 0.000 claims description 2
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 claims description 2
- 239000012046 mixed solvent Substances 0.000 claims description 2
- 241000228212 Aspergillus Species 0.000 claims 1
- 239000004215 Carbon black (E152) Substances 0.000 claims 1
- 229930195733 hydrocarbon Natural products 0.000 claims 1
- 150000002430 hydrocarbons Chemical class 0.000 claims 1
- 230000005923 long-lasting effect Effects 0.000 abstract description 3
- 230000003389 potentiating effect Effects 0.000 abstract 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 48
- 238000012360 testing method Methods 0.000 description 40
- 230000000052 comparative effect Effects 0.000 description 38
- 230000001954 sterilising effect Effects 0.000 description 35
- 235000015278 beef Nutrition 0.000 description 32
- 229940007062 eucalyptus extract Drugs 0.000 description 30
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 29
- 239000004310 lactic acid Substances 0.000 description 24
- 235000014655 lactic acid Nutrition 0.000 description 24
- 238000004659 sterilization and disinfection Methods 0.000 description 24
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 23
- 238000004519 manufacturing process Methods 0.000 description 20
- 239000000203 mixture Substances 0.000 description 20
- 239000002504 physiological saline solution Substances 0.000 description 17
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- 241000588724 Escherichia coli Species 0.000 description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- 244000004281 Eucalyptus maculata Species 0.000 description 15
- 230000001580 bacterial effect Effects 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 229910001220 stainless steel Inorganic materials 0.000 description 13
- 239000010935 stainless steel Substances 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- 239000005708 Sodium hypochlorite Substances 0.000 description 12
- 241000191967 Staphylococcus aureus Species 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 12
- 239000003814 drug Substances 0.000 description 12
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 230000002070 germicidal effect Effects 0.000 description 11
- 244000144972 livestock Species 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 239000002253 acid Substances 0.000 description 10
- 244000187657 Eucalyptus crebra Species 0.000 description 9
- 241001233195 Eucalyptus grandis Species 0.000 description 9
- 238000011109 contamination Methods 0.000 description 9
- 230000007423 decrease Effects 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 8
- 235000014469 Bacillus subtilis Nutrition 0.000 description 8
- 240000001414 Eucalyptus viminalis Species 0.000 description 8
- 230000002829 reductive effect Effects 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 244000063299 Bacillus subtilis Species 0.000 description 7
- 241000186427 Cutibacterium acnes Species 0.000 description 7
- 241001465371 Eucalyptus botryoides Species 0.000 description 7
- 244000165963 Eucalyptus camaldulensis Species 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 235000013601 eggs Nutrition 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 229940055019 propionibacterium acne Drugs 0.000 description 7
- 230000002195 synergetic effect Effects 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 102000002322 Egg Proteins Human genes 0.000 description 6
- 108010000912 Egg Proteins Proteins 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 241000607142 Salmonella Species 0.000 description 6
- 241001045770 Trichophyton mentagrophytes Species 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- 230000002688 persistence Effects 0.000 description 6
- 241000193755 Bacillus cereus Species 0.000 description 5
- 229920000742 Cotton Polymers 0.000 description 5
- 235000004692 Eucalyptus globulus Nutrition 0.000 description 5
- 235000010705 Eucalyptus maculata Nutrition 0.000 description 5
- 235000013366 Eucalyptus viminalis Nutrition 0.000 description 5
- 241000233866 Fungi Species 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 241000589776 Pseudomonas putida Species 0.000 description 5
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 5
- 229960000583 acetic acid Drugs 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 241000287828 Gallus gallus Species 0.000 description 4
- 241000588767 Proteus vulgaris Species 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 235000013330 chicken meat Nutrition 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 230000000249 desinfective effect Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 229940007042 proteus vulgaris Drugs 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- 241000228245 Aspergillus niger Species 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- 229920002101 Chitin Polymers 0.000 description 3
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 3
- 241000228153 Penicillium citrinum Species 0.000 description 3
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 239000007857 degradation product Substances 0.000 description 3
- 238000005238 degreasing Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000000469 ethanolic extract Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000012454 non-polar solvent Substances 0.000 description 3
- 230000000474 nursing effect Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 244000144977 poultry Species 0.000 description 3
- 235000013594 poultry meat Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 3
- 201000004647 tinea pedis Diseases 0.000 description 3
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- NGJANBBWZSMYRM-UHFFFAOYSA-N 2,4,6-Trihydroxy-3-methyl-5-(3-methylbutanoyl)benzaldehyde Chemical compound CC(C)CC(=O)C1=C(O)C(C)=C(O)C(C=O)=C1O NGJANBBWZSMYRM-UHFFFAOYSA-N 0.000 description 2
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 2
- QPWOSZAYIILLKU-UHFFFAOYSA-N 5-Hydroxy-4',7-dimethoxy-6-methylflavone Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C(C)=C(OC)C=C2O1 QPWOSZAYIILLKU-UHFFFAOYSA-N 0.000 description 2
- NHMMAMIRMITGRD-UHFFFAOYSA-N 5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-6,8-dimethylchromen-4-one Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C(C)=C(OC)C(C)=C2O1 NHMMAMIRMITGRD-UHFFFAOYSA-N 0.000 description 2
- 241000186063 Arthrobacter Species 0.000 description 2
- 241000186074 Arthrobacter globiformis Species 0.000 description 2
- 244000177578 Bacterium linens Species 0.000 description 2
- 235000012539 Bacterium linens Nutrition 0.000 description 2
- 241000186146 Brevibacterium Species 0.000 description 2
- 241001596130 Bruceiella globulus Species 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 206010012444 Dermatitis diaper Diseases 0.000 description 2
- 208000003105 Diaper Rash Diseases 0.000 description 2
- 206010016952 Food poisoning Diseases 0.000 description 2
- 208000019331 Foodborne disease Diseases 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 2
- 241000295644 Staphylococcaceae Species 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 241000607598 Vibrio Species 0.000 description 2
- 241000607272 Vibrio parahaemolyticus Species 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 239000002781 deodorant agent Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 239000002038 ethyl acetate fraction Substances 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- QBKSWRVVCFFDOT-UHFFFAOYSA-N gossypol Chemical compound CC(C)C1=C(O)C(O)=C(C=O)C2=C(O)C(C=3C(O)=C4C(C=O)=C(O)C(O)=C(C4=CC=3C)C(C)C)=C(C)C=C21 QBKSWRVVCFFDOT-UHFFFAOYSA-N 0.000 description 2
- 150000008282 halocarbons Chemical class 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229960003085 meticillin Drugs 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 235000012149 noodles Nutrition 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 235000013580 sausages Nutrition 0.000 description 2
- 239000001540 sodium lactate Substances 0.000 description 2
- 235000011088 sodium lactate Nutrition 0.000 description 2
- 229940005581 sodium lactate Drugs 0.000 description 2
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- IBLPTYJTKWQCDX-MOTAWSDJSA-N 5-[(1r)-1-[(1ar,4r,4ar,7s,7as,7br)-4-hydroxy-1,1,4,7-tetramethyl-1a,2,3,4a,5,6,7a,7b-octahydrocyclopropa[h]azulen-7-yl]-3-methylbutyl]-2,4,6-trihydroxybenzene-1,3-dicarbaldehyde Chemical compound C1([C@H](CC(C)C)[C@]2(C)[C@@H]3[C@H]([C@](CC[C@@H]4[C@H]3C4(C)C)(C)O)CC2)=C(O)C(C=O)=C(O)C(C=O)=C1O IBLPTYJTKWQCDX-MOTAWSDJSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 208000020154 Acnes Diseases 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000145784 Boulengerella maculata Species 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 239000005714 Chitosan hydrochloride Substances 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000951471 Citrus junos Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000004267 EU approved acidity regulator Substances 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 229930185299 Eucalyptin Natural products 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 241001493731 Eucalyptus macrocarpa Species 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- UIOFUWFRIANQPC-JKIFEVAISA-N Floxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl UIOFUWFRIANQPC-JKIFEVAISA-N 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- FEWJPZIEWOKRBE-XIXRPRMCSA-N Mesotartaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-XIXRPRMCSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 240000008881 Oenanthe javanica Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- LUSZGTFNYDARNI-UHFFFAOYSA-N Sesamol Natural products OC1=CC=C2OCOC2=C1 LUSZGTFNYDARNI-UHFFFAOYSA-N 0.000 description 1
- ZZMNWJVJUKMZJY-AFHBHXEDSA-N Sesamolin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-AFHBHXEDSA-N 0.000 description 1
- ZZMNWJVJUKMZJY-UHFFFAOYSA-N Sesamolin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000001744 Sodium fumarate Substances 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000256670 Termitomyces globulus Species 0.000 description 1
- QHOPXUFELLHKAS-UHFFFAOYSA-N Thespesin Natural products CC(C)c1c(O)c(O)c2C(O)Oc3c(c(C)cc1c23)-c1c2OC(O)c3c(O)c(O)c(C(C)C)c(cc1C)c23 QHOPXUFELLHKAS-UHFFFAOYSA-N 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 241000383730 Tuberolachnus salignus Species 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- 241000750042 Vini Species 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 238000001856 aerosol method Methods 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 238000003975 animal breeding Methods 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000006196 deacetylation Effects 0.000 description 1
- 238000003381 deacetylation reaction Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical class C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- MSJMDZAOKORVFC-SEPHDYHBSA-L disodium fumarate Chemical compound [Na+].[Na+].[O-]C(=O)\C=C\C([O-])=O MSJMDZAOKORVFC-SEPHDYHBSA-L 0.000 description 1
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 description 1
- 229940048879 dl tartaric acid Drugs 0.000 description 1
- 238000002451 electron ionisation mass spectrometry Methods 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- IBLPTYJTKWQCDX-UHFFFAOYSA-N euvimal-1 Natural products C1CC(C(CCC2C3C2(C)C)(C)O)C3C1(C)C(CC(C)C)C1=C(O)C(C=O)=C(O)C(C=O)=C1O IBLPTYJTKWQCDX-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229940002508 ginger extract Drugs 0.000 description 1
- 235000020708 ginger extract Nutrition 0.000 description 1
- 235000012209 glucono delta-lactone Nutrition 0.000 description 1
- 239000000182 glucono-delta-lactone Substances 0.000 description 1
- 229960003681 gluconolactone Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- 229930000755 gossypol Natural products 0.000 description 1
- 229950005277 gossypol Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000003569 mottlecah Nutrition 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000001965 potato dextrose agar Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229960004249 sodium acetate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000019294 sodium fumarate Nutrition 0.000 description 1
- 229940005573 sodium fumarate Drugs 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- HELHAJAZNSDZJO-UHFFFAOYSA-L sodium tartrate Chemical compound [Na+].[Na+].[O-]C(=O)C(O)C(O)C([O-])=O HELHAJAZNSDZJO-UHFFFAOYSA-L 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A23L3/3499—
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N35/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
- A01N35/04—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing aldehyde or keto groups, or thio analogues thereof, directly attached to an aromatic ring system, e.g. acetophenone; Derivatives thereof, e.g. acetals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
- A01N43/14—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings
- A01N43/16—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings with oxygen as the ring hetero atom
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
- A01N65/28—Myrtaceae [Myrtle family], e.g. teatree or clove
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/24—Organic nitrogen compounds
- A21D2/26—Proteins
- A21D2/264—Vegetable proteins
- A21D2/265—Vegetable proteins from cereals, flour, bran
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K30/00—Processes specially adapted for preservation of materials in order to produce animal feeding-stuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
-
- A23L3/3472—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
- Y02A40/818—Alternative feeds for fish, e.g. in aquacultures
Definitions
- the present invention relates to a fungicide derived from a natural product, in particular, a fungicide containing a polar organic solvent extract of eucalyptus plant leaves and chitosan, or a fungicide to which a glycerin fatty acid ester is further added. Also, it relates to a highly safe bactericide that has a long germicidal activity.
- the disinfectant according to the present invention can be used in households, restaurants, medical facilities, nursing homes, meat processing facilities, livestock pens, poultry houses, and the like. It is especially useful as a fungicide to prevent cane and athlete's foot.
- chitosan is a deacetylated version of chitin contained in the shells of Rinji, and is also used as a food additive.
- Examples of reports of synergistic effects when two or more antimicrobial components are mixed include rifampicin and chitosan (JP-A-59-46208), sulfonamides and chitosan (JP-A-59-46223), and chitosan.
- Examples of the combination of a cut flower activator (JP-A-4-3165G6) and a plant pest control agent (JP-A-7-0336G2) with a yuri extract and chitosan have been reported. Is not described.
- Acne is induced by the proliferation of acne bacteria (Propionibacterium acnes) present in the sebaceous glands. Athlete's foot is induced by infection with Trichophyton mentagrophytes. Therefore, if acne fungus and ringworm can be effectively killed, it will be possible to prevent acne and athlete's foot.
- acne bacteria Propionibacterium acnes
- meat processing machines In the meat processing plant, meat processing machines (meat grinders, silent cutters, slicers, blenders, etc.) using food poisoning bacteria such as pathogenic Escherichia coli, Salmonella enteritidis, and Staphylococcus aureus, etc. Contamination of filling machines, meat dehydrators, etc.) and processing facilities is a problem.
- Pathogenic Escherichia coli Escherichia coli
- livestock such as cattle, sheep and pigs
- Salmonella la enter it idis is transmitted through chickens and eggs, which is a problem.
- a livestock barn is contaminated with pathogens
- the contamination may spread through the livestock and the hands of people who come into contact with the livestock in the livestock barc. It is important to.
- problems such as contamination of the feed by bacteria and propagation of bacteria in the feed occur.
- the present invention has high safety, has a bactericidal activity against the above-mentioned pathogenic bacteria at a low concentration, has a high sustainability of the bactericidal activity, and has no decrease in the bactericidal activity during sterilization in the meat sterilizing process.
- the objective is to provide a disinfectant that can be used repeatedly in the disinfection step. Disclosure of the invention
- the present inventors have found that a bactericide containing a polar organic solvent extract of Yuri genus and chitosan exerts a bactericidal activity at a low concentration due to a synergistic effect of the extract of Yururi and phytosan, and sustains the bactericidal activity. It was found that when used as a bactericide for meat (including processed foods such as ham and sausage), the bactericidal activity did not decrease. Furthermore, when a glycerin fatty acid ester is added to the fungicide having the above composition, the sustainability of the bactericidal activity is improved, and the action of the eucalyptus extract enhances the drag force of the glycerin fatty acid ester. I found something.
- the present invention is based on the fact that the present invention comprises a polar solvent extract of a leaf of a Yuri plant and chitosan, and if necessary, further comprises a bactericide further containing a glycerin fatty acid ester. It is selected from lower grades of alcohol or glycols.
- examples of the polar organic solvent extract of the leaves of Eucalyptus plants include fractions obtained by extracting the leaves of Eucalyptus plants from which the essential oil has been removed by degreasing with a nonpolar organic solvent or by steam distillation with a polar organic solvent.
- Examples of the polar organic solvent used here include a solvent selected from halogenated hydrocarbons, ethers, lower fatty acid esters, ketones, and lower alcohols, or a mixed solvent thereof, and examples of the nonpolar organic solvent include lucan.
- Examples of the polar solvent extract of the leaves of the plant of the genus Euryri include an extract containing a dihydro sigma lucone compound represented by the following formula (I) as a main bactericidal component.
- the disinfectant of the present invention can be used for disinfection of medical facilities, meat processing facilities, livestock pens, poultry houses, avian eggshells, meat, etc., and has a disinfecting power when formulated in feeds, wet tissues, diapers and the like. It is used when adding.
- the fungicide of the present invention has high safety for the human body because it uses natural products, for which safety is already known, as an active ingredient.
- “sterilization” is a concept that includes both killing microorganisms such as bacteria and inhibiting growth.
- the “meat processing facility” includes facilities or machines attached to the meat processing plant, and cooking utensils or tables such as cutting tools used for meat processing.
- the polar organic solvent extract of Eucalyptus plants used in the fungicide of the present invention (hereinafter, referred to as “ultra-rich extract”) is an extract obtained by extracting leaves of a Eucalyptus plant with a polar organic solvent. It is.
- the leaves used as raw materials can be any leaves of plants belonging to the genus Yuri, and include the following species: Yupuri liptus 'Grandeis (Eucalyptus grandis), euca liptus' Bollio Ides (Eucalyptus botryoides), eucalyptus 'gloplus' Bucalypt us gl obul us), Eucalyptus camaldu lensis, Eucalyptus crebra, Eucalyptus crebra, Buca lyptus maculata, Eucalyptus bimy Buca Plant leaves such as lyptus v iminal is) can be used. These eucalyptus leaves may be leaves of a single plant or a combination of leaves from two or more kinds of plants.
- Such leaves of Yuri plants are extracted with a polar organic solvent. That is, prior to extraction, the leaves are pre-treated such as crushing to an appropriate size or pulverizing so as to facilitate solvent extraction.
- polar organic solvents include halogenated hydrocarbons such as chloroform, dichloromethane, dichloroethane, and trichloroethane; ethers such as methyl ether, ethyl ether, tetrahydrofuran, and dioxane; and lower fatty acids such as methyl acetate, ethyl acetate, and butyl acetate.
- These solvents may be used alone, or may be used as a mixture of two or more optional solvents.
- ethyl acetate, acetone, ethanol, propylene glycol, and butylene glycol are preferred from the viewpoint of the bactericidal activity of the obtained extract, and ethanol and propylene glycol are more preferred.
- the extraction method may be a commonly used method, for example, a method of immersing the raw Yuri leaves in a polar organic solvent for a long time, or performing extraction while heating and stirring at a temperature below the boiling point of the polar organic solvent.
- a method of obtaining an extract by filtration is preferably concentrated by vacuum concentration or the like.
- a preferred embodiment is one in which the oil is defatted with an organic solvent to remove the essential oil and then extracted with a polar organic solvent.
- the essential oil is removed in the process of defatting with a non-polar solvent.
- This operation can also be performed by a method in which a polar solvent is added to the residue after removing the essential oil by steam distillation to extract the residue.
- the non-polar solvent include alkanes such as hexane, pentane and heptane.
- the defatting operation is not particularly essential to the present invention, and a fraction obtained by directly extracting leaves of a plant belonging to the genus Eucalyptus with a polar organic solvent can also be used as the fungicide of the present invention.
- the polar organic solvent include lower alcohols and glycols such as propylene glycol and butylene glycol.
- the leaf extract of Eucalyptus macrata contains a novel dihydro ⁇ -chalcone compound represented by the formula (I) and a known flavone compound (eucalypt in and 8-desmethyl-euca liptin (Aust. J. Chem. 17, 692, 1964; Aust. J. Chera. 17, 464 1964). It is thought that the fungicidal compounds contained in eucalyptus leaves include compounds other than these compounds. However, when preparing the Eucalyptus extract used in the present invention, these compounds or their analogs are considered. It is presumed that the body can be used as an indicator.
- Yuri extract used in the present invention, an extract containing at least one or two or more of the above-mentioned dihydrochalcone compounds or flavone compounds or analogs thereof as a main bactericidal component Or purified compounds or analogs thereof.
- Tosan (poly / 9-11,4-darcosamine) is a deacetylated product of chitin, for example, chitin contained in shells of crustaceans such as Rikiji and shrimp, or in the exoskeleton of insects. It is obtained by deacetylation in a highly concentrated hot alkaline solution. Moreover, it can also be obtained by culturing chitosan-producing bacteria. Commercial products can also be used.
- the molecular weight of chitosan used in the present invention is not particularly limited, but it is preferably low in viscosity, and preferably about 5 to 50 cp (0.5% chitosan concentration). Also water soluble Chitosan oligosaccharides with enhanced properties, chitosan derivatives such as chitosan lactate and chitosan hydrochloride can be used, but in order to prepare a bactericidal agent having a strong bactericidal activity, it is preferable to use chitosan.
- Yuri extract and chitosan can be appropriately changed depending on the mode of use and the dosage form. For example, they are added in a total of 0.001 to 1 (% by weight), preferably Q. 01-1. (Examples include about 3% by weight.
- non-volatile glycols such as propylene glycol, butylene glycol, etc.
- the eucalyptus extract is contained in an amount of about 0.1 to 10% by volume Exceeding the upper limit of this range may affect the aroma of the bactericide.
- the above range is preferable, since the effect may be less likely to be obtained when the concentration is lower than the above range.
- the Yuri power extract and chitosan can be mixed at an arbitrary ratio within the above concentration range.
- the dissolving acid lactic acid, acetic acid, etc.
- a glycerin fatty acid ester can be further added to the bactericide having a composition containing a Yuri extract and chitosan.
- 0.001 to 20% by weight, preferably 0.001 to 1.0% by weight of glycerin fatty acid ester is added to the composition containing the Yuri extract and chitosan. .
- the pH of the fungicide increases due to the effect of components dissolved from beef during sterilization, and the sterilizing power decreases when the pH exceeds 5.5.
- An acid such as lactic acid or acetic acid or a pH adjuster is added so as to maintain the pH of the fungicide at 5.5 or less, preferably 5.0 or less.
- bactericide of the present invention in a range that does not impair the effects of the present invention, food, Various components commonly used in pharmaceuticals, quasi-drugs, cosmetics, etc., and components used in acidity regulators, stabilizers, surfactants, antioxidants, etc. can be blended. You may mix
- Examples of various components generally used in foods, pharmaceuticals, quasi-drugs, cosmetics, and the like include surfactants (anionic, cationic, amphoteric or nonionic surfactants), antioxidants (stealin, etc.). Acid esters, nordihydroxide, selethenic acid, dibutylhydroxytoluene, butylhydroxyanisole, norahydroxyloxyisanol, propyl gallate, sesamol, sesamolin, gossypol, etc.), humectants (propylene glycol, 1, 3-butylene glycol, polyethylene glycol, glycerin, chondroitin sulfate and its salts, hyaluronic acid and its salts, sodium lactate, royal jelly extract, etc.)
- Examples of the acidity adjusting and function stabilizing agents include adipic acid, citric acid, sodium sodium citrate, glycine, glycerin fatty acid ester, gluconodelta lactone, dalconic acid, succinic acid, sodium succinate, Sodium sodium succinate, acetic acid, sodium acetate, DL-tartaric acid, L-tartaric acid, sodium sodium monotartrate, sodium L-tartrate, carbonates, carbon dioxide, lactic acid, sodium lactate, fumaric acid, Examples include sodium fumarate, lysozyme, DL-linkic acid, DL-sodium phosphate, phosphoric acid, phosphates, polymerized phosphates, itaconic acid, phytic acid, and the like. .
- surfactant examples include glycerol fatty acid esters such as glycerol monostearate and polyglycerol trioleate, and monoglycerides of organic acids.
- glycerol fatty acid esters such as glycerol monostearate and polyglycerol trioleate
- monoglycerides of organic acids include glycerol fatty acid esters such as glycerol monostearate and polyglycerol trioleate, and monoglycerides of organic acids.
- Antioxidants include catechin, tocoprol, propolis, ellagic acid, and plant and animal extracts (sage, seri, rosemary, etc.).
- the fungicide is not particularly limited as long as it is a substance or an extract having a bactericidal activity.
- examples thereof include hinokitiol, triclosan, cetylpyridinium chloride, chlorhexidine gluconate, animal and plant extracts, and essential oils.
- the fungicide containing the extract of the genus Yuri and the chitosan is a synergistic effect of the extract of the genus Erythium and chitosan, resulting in methicillin-resistant staphylococci (MRS A), ⁇ Rius (Staphylococcus aureus), Escherichia coli (Escherichia coli), Salmonella typh imurium (Salmonella typh imurium), Salmonel la enteritidis (Shenmonel la enteritidis), is), Pseudomonas putida, Bacillus subtilis (Baci 1 lus subtilis) f (Sa.
- rp Bacillus cereus
- Vibrio Vibrio par ahaemolyticus
- R click human, 'ho j Remisu (Arthrobacter globif or mis), Brevibacterium Rinensu (Brevibacterium linens), up 1 ⁇ lax vulgaris (Proteus vulgaris), It exerts a strong bactericidal activity against Propionobacteriura acnes and Trichophyton metagriphytes, and has a long-lasting bactericidal activity.
- Both the extract and chitosan are highly safe, and by selecting those with high safety as other components, a highly safe disinfectant can be prepared.
- a glycerin fatty acid ester is added to the composition containing the above-mentioned Yuriki sleeve extract and chitosan.
- the fungicide added also exerts an effect on molds such as Aspergillus niger and Penicillium citrinum due to the synergistic effect of the Uri extract and glycerin fatty acid ester.
- the present disinfectant is prepared as a mixed liquid system of ethanol and water, the instant disinfecting action of ethanol is added, so that the disinfectant is also effective against the above-mentioned force.
- the dosage form of the fungicide of the present invention is not particularly limited. For example, it is determined according to the use mode of the liquid, paste, spray agent, mousse agent and the like, and is appropriately determined according to the use method such as spraying, dipping, coating and wiping.
- This disinfectant is also used as a spray agent, and can be used in restaurants and kitchens of ordinary households.
- eucalyptus extract and chitosan are dissolved in a suitable solvent and used as a sterilizing solution.
- a solvent obtained by adding an acid such as lactic acid or acetic acid for dissolving chitosan to a mixed liquid of ethanol and water (arbitrary ratio) is used.
- the ethanol concentration be in the range of about 0 to 10% when used as a bactericide for meat or the like.
- the above-mentioned acid is added when a chitosan derivative having increased water solubility is used.
- the fungicide according to the present invention is used in a meat sterilizing step, the sterilizing power is reduced. Since no drop occurs, it can be used repeatedly in the sterilization process. This fungicide has the effect of inhibiting the growth of bacteria on the meat surface for a long time when the meat is subjected to a sterilization treatment, so that the meat can be kept fresh for a long time.
- this fungicide is used as a fungicide for bird eggshells
- bird eggs having the fungicide of the present invention adhered to the eggshell surface can be distributed.
- the container for storing the contents may be any container capable of spraying the contents, and examples thereof include aerosol type and trigger type spray containers.
- aerosol type and trigger type spray containers for example, carbon dioxide gas, A spray agent such as nitrogen gas or dimethyl ether is added for use.
- the leaves of Eucalyptus grandis, tiucalyptus botryoiaes, Eucalyptus globulus, Eucalyptus camaldulensis, Eucalyptus crebra, Eucalyptus maculata, and Eucalyptus viminalis are dried (30 g dry weight each), and 500 ml each of acetone. Extracted at room temperature for 3 days. The solvent was distilled off from the extract under reduced pressure to obtain an acetone extract.
- the leaves of U power (Eucalyptus grandis, Eucalyptus botryoides, Eucalyptus globulus, Eucalyptus camaldulensis, Eucalyptus crebra, Eucalyptus maculata, Eucalyptus viminalis) are dried (30 g dry weight each), and each is diluted with 500 ml of ethanol. Extracted at room temperature for days. The solvent was distilled off from the extract under reduced pressure to obtain an ethanol extract.
- the leaves of Eucalyptus grandis, Eucalyptus botryoides, Eucalyptus globulus, Eucalyptus camaldulensis, Eucalyptus crebra, Eucalyptus maculata, Eucalyptus viminalis are dried (30 g dry weight each) and 500 ml each with propylene glycol Extracted at room temperature for 3 days.
- the leaves of Eucalyptus grandis, Eucalyptus botryoides, Eucalyptus glob ulus, Eucalyptus camaldulensis, Eucalyptus crebra, Eucalyptus maculata, Eucalyptus viminalis are dried (3 Qg dry weight each), and
- the acetone extract was first partitioned and extracted with hexane and water.After separating the hexane layer, the remaining aqueous layer was partitioned and extracted with dichloromethane, and further partitioned and extracted with ethyl acetate and n-butanol in that order. did. The ethyl acetate fraction was concentrated as a fraction having a high activity to obtain about 23 g of an ethyl acetate extract (4.6% yield from leaves).
- the ethyl acetate fraction was subjected to silica gel column chromatography, and eluted with a mixture of hexane and ethyl acetate.
- the fraction eluted with a mixture of hexane Z and ethyl acetate 3/1 was concentrated to obtain 3.92 g of an active fraction (yield from leaves 0.78%).
- the compounds (II) and ( ⁇ ) are known flavone compounds eucalyptin and 8-desmethyl-eucalyptin (Aust. J. Chem. 17, 692, 1964; Aust. J. Chem. 17, 464, 1964), respectively, from the physicochemical data. Turned out to be.
- Compound (I) was found to be a novel dihydrochalcone compound from the following physicochemical properties.
- the strain was diluted with physiological saline, and the number of bacteria was adjusted to about 5 ⁇ 10 8 cells / ml.
- the number of spores was adjusted to 5 xlO 6 / ml.
- Propio nibacterium acnes was cultured under anaerobic conditions.
- Table 2 shows the results of the MIC value of each Yuri extract and chitosan.
- the eucalyptus extract has an antibacterial activity that is particularly strong in antibacterial activity, especially against MR A, Staphylococcus auresu, Bnterococcus faecal is, Pseudo monas putida, Bacillus subtilis, Bacillus cereus Arthrofaacter globi formis ⁇ Propionibacterium acnes ⁇ Trichophyton mentagrophytes. It turned out that the spectrum was different. Table 2
- E.gra E. grandis.
- E.bot E. botryoides.
- E.glo E. globulus,
- E.cam £. Camaldutensis,
- E.cre E. crebra.
- E.mac E. moculaia.
- E.vim E. viminalis
- the essential oil was recovered from the leaves of a plant belonging to the genus Yuri by steam distillation, and the minimum inhibitory concentration against various bacteria was determined in the same manner as described above.
- ethanol was used as a solvent for dissolving the essential oil.
- Table 3 shows the MIC values of the essential oils obtained from the genus Yuri, but no strong antibacterial activity was observed in the essential oil fraction.
- E.gra E. grandis.
- E.bot E. botryoides.
- E.glo E. globulus.
- Exam E. camaldulensis.
- E.cre E. crebra.
- E.mac E. macidaia.
- E.vim E. viminalis (2)
- the antibacterial activity of the extract of Preparation Example 5 was examined by the following method.
- the eucalyptus extract of Production Example 5 was diluted 10-fold with sterile distilled water, and the diluted solution was added to each pellet of a 96-liter plate containing 190 jl of the medium shown in Table 1 (extract was 200 parts of undiluted solution). Then, antibacterial activity was examined in the same manner as described above. Table 4 shows the results.
- This extract (200-fold diluted solution) contains MRSA, Staphylococc us auresu, Bnterococcus faecai is, Pseudomonas putida, Bacillus subti lis, Bacillus cereus, Arthrobacter globiformis ⁇ Propionibacterium acnes, Trichophyton gross Showed antibacterial activity.
- E.gra E. grandis
- E.bot E. botiyoides
- E.glo t. Globulus
- E.cam E. cam ldulensis
- Ecre E. crebr.
- E.mac E. maculata.
- E.vim E. viminalis
- the eucalyptus extract of Production Example 2 was dissolved in DMS0 to prepare a two-fold dilution series, and chitosan dissolved in sterile distilled water (to which lactic acid was added) was added to 900 ml of 5 ⁇ -killed bacterial distilled water.
- chitosan dissolved in sterile distilled water (to which lactic acid was added) was added to 900 ml of 5 ⁇ -killed bacterial distilled water.
- bacteria Staphylococcus aureus IF012732, Bacill us subtilis JCM1465, Bacillus subtilis JCM1465, Escherichia coli iFO 12734
- 10 il to the above mixture, 1 hour for S. aureus and B. subtilis, 4 hours for B. coli, and room temperature. I left it. After standing, 1 ml was added to 15ral nutrient agar medium, and cultured for 24 hours under conditions suitable for cultivation of each bacterium, and the presence or absence of growth of the bacterium was observed.
- Table 5 shows the results of S. aureus.
- the minimum bactericidal concentration (the FIC Index was 0.19 based on the MBD value, and the synergistic effect was 0.19 / g / nl and the combination of chitosan and 3 / lug / ral). (The synergistic effect is observed when the FIC Index is 0.5 or less.)
- the results of B. subtilis are shown in Table 6. When combined with 0.5 g / ml of Yururi extract and 3.1 g / ml of chitosan, FIC was The index was 0.312, indicating a synergistic effect.Table 7 shows the results for E.
- Each of the disinfectants shown in Table 8 was impregnated with 25 1 of the paper disks (diameter 8 strokes) sterilized by dry heat and allowed to stand for 7 days.
- the bacterial suspension pre-cultured under the conditions shown in Table 1 was diluted with physiological saline and then impregnated on the paper disc by 10 il. After standing for 1 minute, it was immediately transferred to a test tube containing physiological saline (1 ml), and vortexed for 1 minute to elute the bacteria in the paper disk.
- the physiological saline was diluted, and a certain amount was spread on an agar medium to count viable cells.
- Eizo was used, and 70% ethanol was used as a control for existing fungicides.
- Table 9 shows the results of each example, and Table 1Q shows the results of the comparative example. After applying the fungicide, 7
- Propionibacterium acnes c 10 c 10 c 10
- a paper disc (diameter 8 mm) sterilized by dry heat was impregnated with 25 1 of the disinfectants shown in Table 8 and left for 24 hours to dry the paper disc. 28. Place this paper disc on an agar medium coated with a previously prepared spore suspension of Trichophyton mentagrophytes. After culturing for 5 days at C, it was observed whether an inhibition circle was formed around the paper disk. As a control, 70% ethanol was used as a known bactericide. As shown in Table 11, the fungicide of each Example containing both the eucalyptus extract and chitosan formed a larger inhibition circle than the fungicide containing the Eucalyptus extract alone.
- the fungicide containing chitosan alone did not form an inhibition circle.
- the eucalyptus extract had a long-lasting antibacterial activity against Trichophyton, and the antibacterial activity was enhanced by chitosan.
- Example 2 Example 3 Comparative Example 1 Comparative Example 2 Comparative Example 3 Comparative Example 4 70% ethanol
- Each of the germicides shown in Table 8 was sprayed on a sterilized stainless steel plate (15 UA m 2 ) and left to dry in a sterile room for 7 days.
- a suspension of each bacterium precultured in the same manner as described above was diluted with physiological saline, and then placed on this stainless steel plate. After standing for 10 minutes, the bacteria on the stainless steel plate were wiped off with absorbent cotton, the bacteria were eluted in physiological saline, and the number of viable bacteria was measured.
- Tables 12 and 13 show the results of the examples, and Table 13 shows the results of the comparative examples.
- 70% ethanol was also compared as an existing fungicide.
- the sterilized eggshell surface sprayed with a disinfectant composition shown in Table 8 (15 1 I! 11 2) and allowed to dry at aseptic chamber 7 days. After dilution of the pre-cultured cell suspension with physiological saline, the diluted cell suspension 10 1 was placed on the egg shell surface. After leaving for 10 minutes, degreasing Bacteria on the eggshell surface were wiped off with cotton, and the bacteria were eluted in physiological saline, and the viable count was measured. As a blank, eternal was used, and 70% ethanol was used as a known bactericide for the control. Table 14 shows the results of the examples, and Table 15 shows the results of the comparative examples.
- Example 14 Compared to chitosan alone (Comparative Example 4) and eucalyptus extract alone (Comparative Examples 1 to 3), the bactericide (Examples 1 to 3) containing both the eucalyptus extract and chitosan had a higher bactericidal rate. That is,? The germicidal activity was maintained on the eggshell surface even after the passage of days.Table 14
- the eucalyptus extract, chitosan, glycerin fatty acid ester, and other components of Production Example 2 were mixed at the ratios shown in Table 16 to prepare the fungicides of Example 4 and Comparative Example 5. Yuriki extract and chitosan are shown in% by weight, lactic acid and ethanol in% by volume. Table 16
- the bactericides shown in Table 16 were examined for persistence of the bactericidal activity on stainless steel in the same manner as in Test Example 3 (left for one month). The results are shown in Table 17.
- the Euryli extract of Production Example 5 chitosan, and other components were mixed at the ratios shown in Table 18 to produce the bactericides of Examples 5 to 7.
- Chitosan is expressed in% by weight, eucalyptus extract, and lactic acid in% by volume.
- Table 18 The bactericides shown in Table 18 were tested for persistence of bactericidal activity in the same manner as in Test Example 1 (left standing for? Days). Table 19 shows the results. Even after 7 days from the application of the fungicide, the fungicide of each Example containing both the Yururi extract and chitosan was strong. Sterilization power was maintained
- the eucalyptus extract (B. globulus, E. maculata) of Production Example 3 was mixed with chitosan and other components in the proportions shown in Table 120 to produce the fungicides of Examples 8, 9 and Comparative Examples 6 to 9. did. Eucalyptus and chitosan are% by weight, and lactic acid is% by volume.
- the fungicide containing both the eucalyptus extract and chitosan showed no decrease in the bactericidal activity even when mixed with the beef extract.
- the fungicide containing both eucalyptus extract and chitosan had a higher bactericidal activity than the fungicide containing eucalyptus extract alone (Comparative Examples 6 and 7) and chitosan alone (Comparative Example 8). was found to be strengthened.
- the fungicide of Examples 10 and 11 was prepared by mixing the black extract (B. gl obul us, E. maculata) of Production Example 5 with chitosan and lactic acid in the proportions shown in Table 23. did. In addition, the Yururi extract and lactic acid are volume%, and chitosan is weight%.
- Table 23 The bactericides shown in Table 23 were examined for bactericidal activity in the same manner as in Test Example 7.
- Table 24 shows the results.
- the germicides of each Example had strong bactericidal activity.
- Table 2 4 The bactericides shown in Table 23 were examined for bactericidal activity in the same manner as in Test Example 7.
- Table 24 shows the results.
- the germicides of each Example had strong bactericidal activity.
- the eucalyptus extract of Production Example 5 (B. gl obul us), chitosan, and lactic acid were mixed in the proportions shown in Table 25 to prepare Examples 12, 13 and Comparative Example 1 (a fungicide of K11 was prepared).
- Eucalyptus extract propylene glycol extract
- lactic acid are% by volume
- chitosan is% by weight.
- the bactericide with a lactic acid concentration of 0.30 maintained bactericidal activity against Staphylococcus aureus, but Salmonel la It caused a decrease in bactericidal activity against enteritid.
- the PH of the fungicide increased from 4.2 (before sterilization) to 5.9 (after sterilization).
- the bactericide having a lactic acid concentration of 0.30% maintained strong bactericidal activity against Staphylococcus aureus and Salmonel la enter itidis.
- the pH of the fungicide increased to 3.1 (before sterilization)-4.8 (after sterilization).
- the pH of the disinfectant increases due to the effect of the components eluted from the beef during the beef disinfection, causing a decrease in the disinfectant power. It was found that maintaining a low level (up to around PH 4.8) can prevent a decrease in bactericidal activity.
- Example 12 Comparative Example 10
- 50 ml of each disinfectant was placed in the container, and then 15 g of beef (block) was immersed in this disinfectant and allowed to stand at room temperature (surface disinfection). After 5 minutes, the germicide was removed and only the beef was stored in the container at 4 t :. After a certain time (1 day, 2), 3) 6) 25 ml of physiological saline was added to the beef container and shaken. The number of bacteria on the beef surface eluted in physiological saline was measured. Preliminary experiments confirmed that the number of bacteria on the surface of beef before sterilization was 1Q per gram of beef, £ 1. Sterile water and sodium hypochlorite were also compared.
- Table 27 shows the number of bacteria (per g of beef) present on the beef surface after treatment with the fungicide.
- a fungicide containing both eucalyptus extract and chitosan Example 9
- bacterial growth on the beef surface was greater than when beef was treated with sterile water and 0.01% sodium hypochlorite. An inhibitory effect was observed.
- Feeds having the composition shown in Table 28 were prepared and sterilized by dry heat. Each component is% by weight.
- the Yururi extract (B. gl obul us) of Production Example 2 was mixed with chitosan and other components in the proportions shown in Table 29, and shown in Example 14 and Comparative Example 11 12 A fungicide of the composition was prepared.
- the weight of Yuriki extract and chitosan is% by weight, and the volume of lactic acid, ethanol and sterilized water is% by volume.
- the fungicides 10 ml of Examples 14 and Comparative Examples 11 and 12 shown in Table 29 were mixed with 10 g of the feed shown in Table 28 and dried.
- Escherichia coli Escherichia coli I F012734 pre-cultured under the conditions shown in Table 1 was diluted with physiological saline in 1 g of the feed, and the diluted bacterial solution was impregnated and allowed to stand at room temperature. After a certain period of time (3 days, 6 days, 15 days), saline was added to the feed and stirred to release bacteria present in the feed. The number of viable bacteria present in this physiological saline was examined, and the number of viable bacteria per gram of feed was determined. The results are shown in Table 3Q. The growth of the bacteria was suppressed in the feed (Example 14) containing the Yururi extract and chitosan as compared with the control (Comparative Examples 11 and 12). Feed sterilization power
- the fungicide of Example 16 and Comparative Example 14 were prepared by mixing the ginger extract of Production Example 2, chitosan, and other components in the proportions shown in Table 33.
- the Yururi extract and chitosan are indicated by weight%, and lactic acid is indicated by volume%.
- the eucalyptus extract, chitosan, glycerin fatty acid ester, and other components of Production Example 2 were mixed in the proportions shown in Table 35 to produce the fungicides of Example 17 and Comparative Example 15.
- the weight percentage of eucalyptus extract and chitosan is glycerin fatty acid ester and lactic acid by volume-Table 35
- a spore suspension 501 of Aspergillus niger IF09455, Penicillium citrinum IFD6352 was added to a sterile test tube containing 1 ml of the bactericide shown in Table 35, and the mixture was stirred and allowed to stand at room temperature. One hour later, an aliquot was applied to a potato dextrose medium and the number of viable bacteria (viable cell count) was determined. The results are shown in Table 36.
- the fungicide (Example 17) to which both the Yuri extract and the glycerin fatty acid ester were added was the Uri extract only (Comparative Example 15), the glycerin fatty acid. Compared with the ester alone (Comparative Example 1),
- Example 17 100 ml of the disinfectant of Example 17 shown in Table 35 was immersed in 15 g of diaper base paper (30 x 65 cm) and dried to prepare a disposable diaper. Square this disposable diaper (1 X lcm) After sterilizing in an autoclave, the cells were placed on a potato dextrose agar medium to which a spore suspension of mold (Aspergillus niger, Penicillium citrinum) was previously applied, and cultured at 28 t for 7 days. In addition, a disposable diaper not impregnated with a germicide was used as a control. Table 37 shows the results. It was found that the fungicide of Example 17 formed an inhibitory circle (halo) and had antifungal activity. Table 3 7
- the eucalyptus extract of Production Example 2 (B. globulus and B. maculata) was dissolved in ethanol olive oil (1Z1) and orally administered to 45-day-old mice (using 10 mice in each test section), and It was injected subcutaneously (use 10 animals in each test section).
- Acute toxicity tests were performed on 6 levels from 0.5 to 145 g / kg for oral administration and 6 levels from 0.3 to 6.5 g / kg for subcutaneous injection, and the condition of the mice was observed for 2 weeks. The mice survived in any of the test plots, and no abnormal skin was observed. That this toxicity test results are much higher than mice injected subcutaneously LD 5 D> 0.2g / kg is acute toxicity criteria for MHW ordinary drugs, it is very safe pharmaceutical, quasi drugs Is shown.
- the bactericide according to the present invention is:
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Botany (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Plant Pathology (AREA)
- Agronomy & Crop Science (AREA)
- Birds (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pest Control & Pesticides (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Insects & Arthropods (AREA)
- Marine Sciences & Fisheries (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Plant Substances (AREA)
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU32764/99A AU3276499A (en) | 1998-03-12 | 1999-03-11 | Bactericides |
US09/623,453 US6352727B1 (en) | 1998-03-12 | 1999-03-11 | Bactericides |
EP19990939151 EP1062871B1 (en) | 1998-03-12 | 1999-03-11 | Bactericides |
CA 2323419 CA2323419C (en) | 1998-03-12 | 1999-03-11 | Bactericide |
DE1999637339 DE69937339T2 (de) | 1998-03-12 | 1999-03-11 | Bakterizide |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6179998 | 1998-03-12 | ||
JP6180098 | 1998-03-12 | ||
JP10/61799 | 1998-03-12 | ||
JP10/61800 | 1998-03-12 | ||
JP10/87782 | 1998-03-31 | ||
JP8778298 | 1998-03-31 | ||
JP10/89052 | 1998-04-01 | ||
JP8905298 | 1998-04-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999045784A1 true WO1999045784A1 (fr) | 1999-09-16 |
Family
ID=27464085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1999/001183 WO1999045784A1 (fr) | 1998-03-12 | 1999-03-11 | Bactericides |
Country Status (7)
Country | Link |
---|---|
US (1) | US6352727B1 (ja) |
EP (1) | EP1062871B1 (ja) |
CN (1) | CN1321573C (ja) |
AU (1) | AU3276499A (ja) |
CA (1) | CA2323419C (ja) |
DE (1) | DE69937339T2 (ja) |
WO (1) | WO1999045784A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1190715A1 (en) * | 1999-08-23 | 2002-03-27 | Kazuo Iwai | Bactericide against vancomycin resistant enterococcus |
CN105780598A (zh) * | 2016-03-28 | 2016-07-20 | 沙洲职业工学院 | 一种包装用芳香防虫特种纸的生产方法 |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0024489D0 (en) * | 2000-10-06 | 2000-11-22 | Reckitt Benckiser Uk Ltd | Improvements in or relating to organic compositions |
AUPR484201A0 (en) * | 2001-05-08 | 2001-05-31 | Bioprospect Limited | Pesticidal compositions |
JP2003102373A (ja) * | 2001-09-28 | 2003-04-08 | Jcs:Kk | 食鳥肉の殺菌方法 |
US20030100254A1 (en) * | 2001-11-29 | 2003-05-29 | Kazuo Iwai | Method of sterilizing mammal carcasses |
GB2384985A (en) * | 2002-02-12 | 2003-08-13 | Barry Siberry | Cures and preventions for fungal infections in humans and animals |
US20050032896A1 (en) * | 2002-06-21 | 2005-02-10 | Liisa Neumann | Use of synthetic retinoic acid in form of 13-cis vitamin A for treatment of autism |
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
BR0317923A (pt) * | 2003-01-03 | 2005-11-29 | Nutra Park Inc | Métodos para modificar uma planta ou parte de planta, para elicitar a resposta hipersensìvel em uma planta ou parte de planta e para aumentar a atividade total de uma enzima e a sìntese de lignina em uma planta ou parte de planta |
JP2007505125A (ja) * | 2003-09-09 | 2007-03-08 | スリーエム イノベイティブ プロパティズ カンパニー | 抗菌性組成物および方法 |
US20050058673A1 (en) * | 2003-09-09 | 2005-03-17 | 3M Innovative Properties Company | Antimicrobial compositions and methods |
MXPA06002715A (es) * | 2003-09-09 | 2006-06-05 | 3M Innovative Properties Co | Composiciones antimicrobianas concentradas y metodos. |
US20050196497A1 (en) * | 2004-03-03 | 2005-09-08 | Kraft Foods Holdings, Inc. | Antimicrobial effect of chitosan in beverages |
US20050260138A1 (en) * | 2004-05-21 | 2005-11-24 | Virgil Flanigan | Producton and use of a gaseous vapor disinfectant |
US7354888B2 (en) * | 2004-11-10 | 2008-04-08 | Danisco A/S | Antibacterial composition and methods thereof comprising a ternary builder mixture |
US20060140883A1 (en) * | 2004-12-29 | 2006-06-29 | Colgate-Palmolive Company | Oral care compositions containing a eucalyptus extract |
MX2007010904A (es) * | 2005-03-10 | 2007-12-05 | 3M Innovative Properties Co | Panuelo para mascota antimicrobiano. |
US20060229364A1 (en) * | 2005-03-10 | 2006-10-12 | 3M Innovative Properties Company | Antiviral compositions and methods of use |
US10918618B2 (en) * | 2005-03-10 | 2021-02-16 | 3M Innovative Properties Company | Methods of reducing microbial contamination |
EP1858506A2 (en) * | 2005-03-10 | 2007-11-28 | 3M Innovative Properties Company | Methods of treating ear infections |
EP1898900B1 (en) * | 2005-03-10 | 2011-06-08 | 3M Innovative Properties Company | Antimicrobial compositions comprising esters of hydroxycarboxylic acids |
CA2604352A1 (en) * | 2005-04-01 | 2006-10-05 | Universite Laval | Garlic extract and chitosan compositions, and uses thereof |
US20070026765A1 (en) * | 2005-08-01 | 2007-02-01 | Renn Richard M | Composition and method for the control of parasitic mites of honey bees |
US20090321534A1 (en) * | 2005-12-02 | 2009-12-31 | Nfd, Llc | Aerosol or gaseous decontaminant generator and application thereof |
US20070142322A1 (en) * | 2005-12-20 | 2007-06-21 | Kaspar Charles W | Method of using chitosan to reduce shedding of E. coli from bovines |
US20090312279A1 (en) * | 2005-12-23 | 2009-12-17 | Sterilex Technologies, Llc | Antimicrobial compositions |
US20070258996A1 (en) * | 2005-12-23 | 2007-11-08 | The Sterilex Corporation | Antimicrobial compositions |
US20080194518A1 (en) * | 2005-12-23 | 2008-08-14 | MOOKERJEE Pradip | Antimicrobial Compositions |
US20080032021A1 (en) * | 2006-05-19 | 2008-02-07 | Faltys Gary L | Feed supplements for ruminants including essential oil compounds and organic acids |
WO2007149868A2 (en) * | 2006-06-20 | 2007-12-27 | The Regents Of The University Of California | Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles |
US20080075793A1 (en) * | 2006-09-21 | 2008-03-27 | Dunshee Wayne K | Antiviral compositions and methods of use |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
WO2009090495A2 (en) | 2007-12-07 | 2009-07-23 | Foamix Ltd. | Oil and liquid silicone foamable carriers and formulations |
DE202008006795U1 (de) | 2008-05-19 | 2008-07-24 | Sommer, Klaus | Biozide Mikroemulsion |
JP5602346B2 (ja) * | 2008-06-17 | 2014-10-08 | 株式会社ロッテ | ユーカリ抽出物の調製方法 |
EP2393386A1 (en) * | 2009-02-04 | 2011-12-14 | Kalamazoo Holdings, Inc. | Compositions and methods for enhancing the stability of foods, beverages, nutritional supplements and cosmetics |
CA2760186C (en) | 2009-04-28 | 2019-10-29 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
MY161546A (en) * | 2009-07-28 | 2017-04-28 | The Energy And Resources Inst (Teri) | Novel biopesticide compositions and method for isolation and characterization of same |
WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
CA2769677A1 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
BR112012007473A2 (pt) | 2009-10-02 | 2019-05-07 | Foamix Ltd | composições tópicas de tetraciclina e respectivo método de uso |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
WO2012018913A1 (en) * | 2010-08-03 | 2012-02-09 | Hill's Pet Nutrition, Inc. | Pet food compositions having antimicrobial activity |
EP2624702B1 (en) * | 2010-10-06 | 2016-03-02 | The Board of Trustees of The University of Arkansas | Anti-biofilm compositions and methods for using |
EP2690959B1 (en) | 2011-03-31 | 2016-03-23 | Novozymes Biologicals, Inc. | Competitive and effective bradyrhizobium japonicum strains |
CA3174662A1 (en) | 2011-09-08 | 2013-03-14 | Novozymes Bioag A/S | Seed treatment methods and compositions |
RU2621554C2 (ru) | 2011-09-14 | 2017-06-06 | Новозимс Биоаг А/С | Применение липохитоолигосахаридов и/или хитоолигосахаридов в комбинации с микроорганизмами, придающими растворимость фосфатам, для усиления роста растений |
MX2014003411A (es) | 2011-09-23 | 2015-03-19 | Novozymes Bioag As | Quitooligosacaridos y metodos para el uso en el mejoramiento del crecimiento del maiz. |
RU2016119957A (ru) | 2011-09-23 | 2018-11-08 | Новозимс Биоаг А/С | Хитоолигосахариды и способы их применения для усиления роста сои |
CN104066327A (zh) | 2011-09-23 | 2014-09-24 | 诺维信生物农业公司 | 用于增强植物生长的脂壳寡糖组合和方法 |
CN104066322B (zh) | 2011-09-23 | 2017-07-04 | 诺维信生物农业公司 | 用于增强植物生长的壳寡糖和方法 |
EP2791366B1 (en) | 2011-12-16 | 2017-04-26 | Novozymes Bioag A/S | Bradyrhizobium strains |
ITMI20120118A1 (it) * | 2012-01-31 | 2013-08-01 | Giuseppe Zummo | Composizione per il trattamento delle malattie della pelle. |
CN103041426A (zh) * | 2012-12-28 | 2013-04-17 | 青岛信锐德科技有限公司 | 生药提取物空气清新剂 |
CN104522070A (zh) * | 2014-12-13 | 2015-04-22 | 广西科技大学 | 巨桉桉叶精油的应用 |
CN105507083A (zh) * | 2015-12-15 | 2016-04-20 | 常熟市众友包装材料有限公司 | 一种安全高效防霉的食品包装纸 |
MX2017011630A (es) | 2016-09-08 | 2018-09-25 | Foamix Pharmaceuticals Ltd | Composiciones y metodos para tratar rosacea y acne. |
CN108042378A (zh) * | 2017-12-19 | 2018-05-18 | 广州净派保洁消毒用品有限公司 | 一种洁肤除菌棉片及其制备方法 |
PT117531B (pt) * | 2021-10-27 | 2024-04-30 | Univ Aveiro | Produto com componentes de eucalyptus globulus para uso como antifúngico, como anti-inflamatório e anti-senescente para aplicação tópica na ausência de citotoxicidade |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS52102421A (en) * | 1976-02-24 | 1977-08-27 | Ezaki Glico Co | Method of preserving foods |
JPS5839615A (ja) * | 1981-09-03 | 1983-03-08 | Lion Corp | 歯磨組成物 |
JPH05306252A (ja) * | 1990-11-22 | 1993-11-19 | Sapporo Breweries Ltd | 新規マクロカルパール類及びその製造法 |
JPH06340484A (ja) * | 1992-07-02 | 1994-12-13 | Seisui:Kk | 魚肉エキスを利用した有機質無農薬肥料とその製造方法 |
JPH0733602A (ja) * | 1993-07-27 | 1995-02-03 | Asahi Optical Co Ltd | 切花活性剤 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5946223A (ja) | 1982-08-30 | 1984-03-15 | Daito Koeki Kk | 抗菌性組成物 |
JPS5946208A (ja) | 1982-08-30 | 1984-03-15 | Daito Koeki Kk | 抗菌性組成物 |
ZA872857B (en) | 1986-05-02 | 1987-11-25 | Warner Lambert Co | Composition and method to inhibit the growth of organisms by the use of bis-biguanido hexanes and essential oil mixture combinations |
JP2681374B2 (ja) | 1988-07-25 | 1997-11-26 | ライオン株式会社 | 酵母あるいは細菌の生育および増殖抑制剤 |
JP3121036B2 (ja) * | 1991-04-12 | 2000-12-25 | 株式会社中埜酢店 | 植物有害生物の防除剤 |
US5518736A (en) * | 1994-06-27 | 1996-05-21 | Yissum Research Development Company Of The Hebrew | Method of preparing natural-oil-containing emulsions and microcapsules and its uses |
-
1999
- 1999-03-11 WO PCT/JP1999/001183 patent/WO1999045784A1/ja active IP Right Grant
- 1999-03-11 AU AU32764/99A patent/AU3276499A/en not_active Abandoned
- 1999-03-11 EP EP19990939151 patent/EP1062871B1/en not_active Expired - Lifetime
- 1999-03-11 CA CA 2323419 patent/CA2323419C/en not_active Expired - Fee Related
- 1999-03-11 US US09/623,453 patent/US6352727B1/en not_active Expired - Fee Related
- 1999-03-11 DE DE1999637339 patent/DE69937339T2/de not_active Expired - Lifetime
- 1999-03-11 CN CNB998061158A patent/CN1321573C/zh not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS52102421A (en) * | 1976-02-24 | 1977-08-27 | Ezaki Glico Co | Method of preserving foods |
JPS5839615A (ja) * | 1981-09-03 | 1983-03-08 | Lion Corp | 歯磨組成物 |
JPH05306252A (ja) * | 1990-11-22 | 1993-11-19 | Sapporo Breweries Ltd | 新規マクロカルパール類及びその製造法 |
JPH06340484A (ja) * | 1992-07-02 | 1994-12-13 | Seisui:Kk | 魚肉エキスを利用した有機質無農薬肥料とその製造方法 |
JPH0733602A (ja) * | 1993-07-27 | 1995-02-03 | Asahi Optical Co Ltd | 切花活性剤 |
Non-Patent Citations (1)
Title |
---|
See also references of EP1062871A4 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1190715A1 (en) * | 1999-08-23 | 2002-03-27 | Kazuo Iwai | Bactericide against vancomycin resistant enterococcus |
US6387417B1 (en) | 1999-08-23 | 2002-05-14 | Kazuo Iwai | Bactericide against vancomycin resistant enterococcus |
CN105780598A (zh) * | 2016-03-28 | 2016-07-20 | 沙洲职业工学院 | 一种包装用芳香防虫特种纸的生产方法 |
Also Published As
Publication number | Publication date |
---|---|
CA2323419A1 (en) | 1999-09-16 |
DE69937339T2 (de) | 2008-02-07 |
CA2323419C (en) | 2009-05-05 |
US6352727B1 (en) | 2002-03-05 |
EP1062871A1 (en) | 2000-12-27 |
AU3276499A (en) | 1999-09-27 |
DE69937339D1 (de) | 2007-11-29 |
EP1062871B1 (en) | 2007-10-17 |
CN1300186A (zh) | 2001-06-20 |
CN1321573C (zh) | 2007-06-20 |
EP1062871A4 (en) | 2004-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999045784A1 (fr) | Bactericides | |
CA2942780C (en) | Antimicrobial composition comprising lauric arginate ethyl ester and hydrogen peroxide | |
JP5890778B2 (ja) | 抗菌性組成物 | |
CN103889464B (zh) | 具有壬酸的抗微生物制剂 | |
Castillo et al. | Reduction of Escherichia coli O157: H7 and Salmonella Typhimurium on beef carcass surfaces using acidified sodium chlorite | |
JP5670201B2 (ja) | A型インフルエンザウイルス属のエンベロープウイルスに対する抗ウイルス剤および抗ウイルス用組成物 | |
JP4258053B2 (ja) | 天然物由来殺菌剤 | |
US11229224B2 (en) | Phytochemical compositions used as disinfectants and food preservatives | |
US20070280982A1 (en) | Antimicrobial compositions comprising hop acid alkali salts and uses thereof | |
JP2012525394A (ja) | 抗菌組成物及び関連使用方法 | |
JP5281808B2 (ja) | 抗菌持続性及び抗ウィルス性を付与する、食品用アルコール除菌剤を用いた食品の除菌方法 | |
AU749901B2 (en) | Antimicrobial composition | |
PL190536B1 (pl) | Dodatek do produktów ulegających rozkładowi mikrobiologicznemu, w szczególności środków spożywczychi kosmetyków, do polepszania trwałości i/lub stabilizowania tych produktów oraz sposób polepszania trwałości i/lub stabilizowania produktów ulegających rozkładowi mikrobiologicznemu w szczególności środków spożywczych i kosmetyków | |
JP2001081007A (ja) | 天然物由来殺菌剤 | |
JP2004509636A (ja) | 食品用水性殺菌/消毒剤 | |
KR101506185B1 (ko) | 4급 암모늄 화합물 내성균을 저해하는 방부조성물 | |
US6554620B1 (en) | Aqueous disinfectant/sterilizing agent for foods | |
WO2000011956A1 (fr) | Compositions bacteriostatiques et bactericides et leurs procedes d'utilisation | |
CN105105279A (zh) | 一种食品防霉杀菌剂 | |
JP2002322009A (ja) | 殺菌用組成物及びその使用方法 | |
CN105251030A (zh) | 一种用于宠物生活环境的可食用的祛味消毒剂及其制备方法 | |
KR20090048902A (ko) | 새싹채소 씨앗 불림액 | |
US20050148518A1 (en) | Anti-bacterial compositions | |
JP2001178433A (ja) | 殺菌剤組成物 | |
WO2019239419A1 (en) | Methanoic acid composition and it's uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 99806115.8 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU BR CA CN ID KR RU US VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2323419 Country of ref document: CA Ref document number: 2323419 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09623453 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999939151 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1999939151 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1999939151 Country of ref document: EP |